These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9276529)

  • 1. Molecular aberrations in the MHC class I-restricted pathway for antigen presentation in methylcholanthrene sarcomas from nude mice: discrepancies between MHC mRNA and surface protein.
    Engel AM; Svane IM; Madsen MW; Pedersen M; Werdelin O
    Clin Exp Immunol; 1997 Aug; 109(2):323-31. PubMed ID: 9276529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma-induced MHC class I expression and defects in Jak/Stat signalling in methylcholanthrene-induced sarcomas.
    Svane IM; Engel AM; Nielsen M; Werdelin O
    Scand J Immunol; 1997 Oct; 46(4):379-87. PubMed ID: 9350289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.
    Garcia-Lora A; Martinez M; Algarra I; Gaforio JJ; Garrido F
    Int J Cancer; 2003 Sep; 106(4):521-527. PubMed ID: 12845647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice.
    Svane IM; Engel AM; Nielsen MB; Ljunggren HG; Rygaard J; Werdelin O
    Eur J Immunol; 1996 Aug; 26(8):1844-50. PubMed ID: 8765030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylcholanthrene-induced sarcomas in nude mice have short induction times and relatively low levels of surface MHC class I expression.
    Engel AM; Svane IM; Mouritsen S; Rygaard J; Clausen J; Werdelin O
    APMIS; 1996 Sep; 104(9):629-39. PubMed ID: 8972687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
    Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
    Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The susceptibility to cytotoxic T lymphocyte mediated lysis of chemically induced sarcomas from immunodeficient and normal mice.
    Svane IM; Engel AM; Thomsen AR; Werdelin O
    Scand J Immunol; 1997 Jan; 45(1):28-35. PubMed ID: 9010497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarities between transplantation antigens on methylcholanthrene-induced sarcomas and T-cell regulatory molecules.
    Flood PM; Deleo AB; Old LJ; Gershon RK
    Ann N Y Acad Sci; 1983; 418():206-19. PubMed ID: 6231877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene.
    Boesen M; Svane IM; Engel AM; Rygaard J; Thomsen AR; Werdelin O
    Clin Exp Immunol; 2000 Aug; 121(2):210-5. PubMed ID: 10931133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells.
    Mangino G; Grazia Capri M; Barnaba V; Alberti S
    Int J Cancer; 2002 Oct; 101(4):353-9. PubMed ID: 12209960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.
    Ono T; Sato S; Kimura N; Tanaka M; Shibuya A; Old LJ; Nakayama E
    Int J Cancer; 2000 Dec; 88(6):845-51. PubMed ID: 11093803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing of exogenous hepatitis B surface antigen particles for Ld-restricted epitope presentation depends on exogenous beta2-microglobulin.
    Schirmbeck R; Thoma S; Reimann J
    Eur J Immunol; 1997 Dec; 27(12):3471-84. PubMed ID: 9464837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCA sarcomas induced in scid mice are more immunogenic than MCA sarcomas induced in congenic, immunocompetent mice.
    Engel AM; Svane IM; Rygaard J; Werdelin O
    Scand J Immunol; 1997 May; 45(5):463-70. PubMed ID: 9160088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of defective antigen processing in human prostate cancer.
    Sanda MG; Restifo NP; Walsh JC; Kawakami Y; Nelson WG; Pardoll DM; Simons JW
    J Natl Cancer Inst; 1995 Feb; 87(4):280-5. PubMed ID: 7707419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression levels of stress protein gp96 are not limiting for major histocompatibility complex class I-restricted antigen presentation.
    Lammert E; Arnold D; Rammensee HG; Schild H
    Eur J Immunol; 1996 Apr; 26(4):875-9. PubMed ID: 8625982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cells of chemically induced tumors differentially express major histocompatibility complex class I antigens.
    Reagan WJ; Pardi D; Callahan GN
    Cancer Invest; 1991; 9(3):269-78. PubMed ID: 1913230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
    Hetttihewa LM
    Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of a shared human prostate cancer-associated antigen by nonclassical MHC-restricted CD8+ T cells.
    Housseau F; Bright RK; Simonis T; Nishimura MI; Topalian SL
    J Immunol; 1999 Dec; 163(11):6330-7. PubMed ID: 10570328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.